These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 23307552

  • 21. Disseminated zygomycosis with involvement of the central nervous system.
    Skiada A, Vrana L, Polychronopoulou H, Prodromou P, Chantzis A, Tofas P, Daikos GL.
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():46-9. PubMed ID: 19754757
    [Abstract] [Full Text] [Related]

  • 22. ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.
    Pagano L, Valentini CG, Caira M, Fianchi L.
    Br J Haematol; 2009 Sep; 146(6):597-606. PubMed ID: 19466966
    [Abstract] [Full Text] [Related]

  • 23. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
    Sansone-Parsons A, Krishna G, Martinho M, Kantesaria B, Gelone S, Mant TG.
    Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
    [Abstract] [Full Text] [Related]

  • 24. Rhino-orbital zygomycosis secondary to Rhizopus oryzae in a renal transplant recipient successfully treated with liposomal amphotericin B.
    Yassin MA, Taj-Aldeen SJ, Khan FY, Errayes M, Aref E.
    Chang Gung Med J; 2008 Jun; 31(4):407-11. PubMed ID: 18935800
    [Abstract] [Full Text] [Related]

  • 25. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
    Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA.
    J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
    [Abstract] [Full Text] [Related]

  • 26. [Rhino-orbital zygomycosis].
    Djokic M, Bojic I, Mikic D, Ivanovic A, Drincic R, Markovic Lj, Bulajic N, Mladenovic T.
    Vojnosanit Pregl; 2001 Feb; 58(5):551-6. PubMed ID: 11769421
    [Abstract] [Full Text] [Related]

  • 27. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
    Petrikkos GL.
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765
    [Abstract] [Full Text] [Related]

  • 28. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman.
    Stewardson AJ, Holmes NE, Ellis DH, Howden BP.
    Mycoses; 2009 Nov; 52(6):547-9. PubMed ID: 19682315
    [Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    Spreghini E, Orlando F, Giannini D, Barchiesi F.
    J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
    [Abstract] [Full Text] [Related]

  • 30. Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant.
    Gilman AL, Serrano A, Skelley J, Zwick D.
    Pediatr Blood Cancer; 2006 Dec; 47(7):959-63. PubMed ID: 16123983
    [Abstract] [Full Text] [Related]

  • 31. Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose.
    Petitcollin A, Boglione-Kerrien C, Tron C, Nimubona S, Lalanne S, Lemaitre F, Bellissant E, Verdier MC.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848009
    [Abstract] [Full Text] [Related]

  • 32. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
    Winston DJ, Bartoni K, Territo MC, Schiller GJ.
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):507-15. PubMed ID: 20460163
    [Abstract] [Full Text] [Related]

  • 33. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
    Chamilos G, Lewis RE, Kontoyiannis DP.
    Clin Infect Dis; 2008 Aug 15; 47(4):503-9. PubMed ID: 18611163
    [Abstract] [Full Text] [Related]

  • 34. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
    Krishna G, Sansone-Parsons A, Kantesaria B.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1415-22. PubMed ID: 17559737
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.
    Valentini CG, Candoni A, Fianchi L, Posteraro B, Simeone E, Costa F, Sanguinetti M, Voso MT, Caira M, Fanin R, Pagano L.
    Mycoses; 2010 Jan 15; 53(1):89-92. PubMed ID: 19207832
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.
    Jancel T, Shaw PA, Hallahan CW, Kim T, Freeman AF, Holland SM, Penzak SR.
    J Clin Pharm Ther; 2017 Feb 15; 42(1):75-79. PubMed ID: 27982447
    [Abstract] [Full Text] [Related]

  • 37. Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
    Leather HL, Correll TA, Meyer CL, Schmalfuss IM, Wingard JR.
    Clin Adv Hematol Oncol; 2005 Oct 15; 3(10):773-7. PubMed ID: 16258487
    [No Abstract] [Full Text] [Related]

  • 38. Posaconazole plasma concentrations in critically ill patients.
    Ray J, Campbell L, Rudham S, Nguyen Q, Marriott D.
    Ther Drug Monit; 2011 Aug 15; 33(4):387-92. PubMed ID: 21654350
    [Abstract] [Full Text] [Related]

  • 39. Review of treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
    Vazquez JA.
    Clin Adv Hematol Oncol; 2005 Oct 15; 3(10):777-8. PubMed ID: 16258488
    [No Abstract] [Full Text] [Related]

  • 40. A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients.
    Thakuria L, Packwood K, Firouzi A, Rogers P, Soresi S, Habibi-Parker K, Lyster H, Zych B, Garcia-Saez D, Mohite P, Patil N, Sabashnikov A, Capoccia M, Chibvuri M, Lamba H, Tate H, Carby M, Simon A, Leaver N, Reed A.
    Int J Antimicrob Agents; 2016 Jan 15; 47(1):69-76. PubMed ID: 26607341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.